anmelden
OMX Copenhagen 20
1.539,57
PKT
+38,10
PKT
+2,54
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 30.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 24.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 17.05.19 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
| 07.05.19 | Novo Nordisk Reduce | HSBC | |
| 06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
| 02.05.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 23.04.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 15.04.19 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
| 11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.04.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.03.19 | Novo Nordisk Reduce | HSBC | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.02.19 | Novo Nordisk Reduce | HSBC |